SCHEMBL28050405

SCHEMBL28050405

CN(C(=O)Oc1ccccc1)[C@H](CO)C(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.53
RAB9A P51151 4/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
L3MBTL1 Q9Y468 3/20 0.45
ALDH1A1 P00352 3/20 0.45
ATM Q13315 2/20 0.45
PKM P14618 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
BCHE P06276 5/20 0.41
ACHE P22303 4/20 0.41
CHRM2 P08172 1/20 0.41
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3475218 0.75 NPY5R (0.59) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL28050443 0.75 NPY5R (0.52) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL28050440 0.75 NPY5R (0.52) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL28050399 0.75 NPY5R (0.52) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL9623297 0.74 NPY5R (0.51) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL21802402 0.73 NPY5R (0.54) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL21802403 0.73 NPY5R (0.54) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL5370760 0.73 NPY5R (0.57) NPY5RRAB9AKMT2AMEN1L3MBTL1
SCHEMBL28274584 0.72 NPY5R (0.47) NPY5RRAB9AKMT2AMEN1NPSR1
SCHEMBL9735895 0.72 NPY5R (0.56) NPY5RRAB9AKMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108434149-A For the regulated treatments of HSPC of Rb positive abnormal cell proliferations G1治疗公司 2018-08-24 CN disclosed
CN-108283644-A To the instantaneous protection of normal cell during chemotherapy G1治疗公司 2018-07-17 CN disclosed
CN-105407889-B HSPC-sparing therapy for Rb-positive abnormal cell proliferation G1治疗公司 2018-06-01 CN disclosed
CN-105473140-B Transient protection of normal cells during chemotherapy G1治疗公司 2018-04-10 CN disclosed
CN-107417691-A Efficient anti-superfluous raw agent and anti-proliferative agent G1治疗公司 2017-12-01 CN disclosed
CN-105473140-A Transient protection of normal cells during chemotherapy G1 THERAPEUTICS INC 2016-04-06 CN disclosed
CN-105407889-A HSPC-sparing therapy for Rb-positive abnormal cell proliferation G1 THERAPEUTICS INC 2016-03-16 CN disclosed
CN-105407723-A Highly effective anti-neoplastic and anti-proliferative agents G1 THERAPEUTICS INC 2016-03-16 CN disclosed